01 septiembre 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Efficacy and Clinical Outcomes of Transcatheter Arterial Embolization for Gastrointestinal Bleeding from Gastrointestinal Stromal Tumor

Hyun Jung Koo, MD, PhD, Ji Hoon Shin, MD, PhD, Sooyoung Shin, MD, Hyun-Ki Yoon, MD, PhD, Gi-Young Ko, MD, PhD, Dong Il Gwon, MD

Purpose: To evaluate the efficacy and clinical outcomes of transcatheter arterial embolization (TAE) for gastrointestinal (GI) bleeding from gastrointestinal stromal tumor (GIST).

01 septiembre 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence

Sohi H. Bae, MD, Man Deuk Kim, MD, Gyoung Min Kim, MD, Shin Jae Lee, MD, Sung Il Park, MD, Jong Yun Won, MD, Do Yun Lee, MD

Purpose: To evaluate the effect of degree of necrosis after uterine artery embolization (UAE) on symptom recurrence at midterm clinical follow-up in patients with adenomyosis.

01 septiembre 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Single-Center Experience Comparing the Application of Small-Caliber versus Large-Caliber Arterial Access Closure in a Consecutive Series of Patients

Frederic Baumann, MD, Timothy Yates, MD, Ripal Gandhi, MD, James Benenati, MD, Constantino Pena, MD, Barry T. Katzen, MD

Purpose: To compare the closure of ≤ 8-F versus 9-F to 12-F femoral access using the 8-F Angio-Seal VIP device (St. Jude Medical, Inc, St. Paul, Minnesota).

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Percutaneous Radiofrequency Ablation of Hepatic Metastases from Gastric Adenocarcinoma after Gastrectomy

Choong Wook Lee, MD, PhD, Jin Hyoung Kim, MD, PhD, Hyung Jin Won, MD, PhD, Yong Moon Shin, MD, PhD, Heung Kyu Ko, MD, PhD, Pyo Nyun Kim, MD, PhD, Min-Hee Ryu, MD, PhD

Purpose: To evaluate the efficacy of percutaneous radiofrequency (RF) ablation for treatment of hepatic metastases from gastric adenocarcinoma.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis

Rex G. Cheng, MD, Renuka Bhattacharya, MD, Matthew M. Yeh, MD, PhD, Siddharth A. Padia, MD

Purpose: To describe full explant pathology and radiographic correlation in patients with hepatocellular carcinoma (HCC) treated with irreversible electroporation (IRE) who subsequently underwent liver transplant.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Preliminary Results in Unresectable Head and Neck Cancer Treated by Radiofrequency and Microwave Ablation: Feasibility, Efficacy, and Safety

Maria Paola Belfiore, MD, Mariacarmela Sciandra, MD, Francesco Romano, MD, PhD, Tommaso Tartaglione, MD, PhD, Guido De Lucia, MD, Tullio Della Volpe, MD, Carmela Buonomo, MD, Salvatore Cappabianca, MD, PhD, Antonio Rotondo, MD, PhD, Giuseppe Belfiore, MD, PhD

Purpose: To retrospectively determine whether the application of thermal ablation to recurrent and advanced head and neck cancer (HNC) could allow for local tumor control.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Proximal Splenic Artery Embolization in Chemotherapy-Induced Thrombocytopenia: A Retrospective Analysis of 13 Patients

Shivank S. Bhatia, MD, Shree Venkat, MD, Ana Echenique, MD, Caio Rocha-Lima, MD, Mehul H. Doshi, MD, Jason Salsamendi, MD, Katuska Barbery, MD, Govindarajan Narayanan, MD

Purpose: To determine if proximal splenic artery embolization (PSAE) provides a safe and effective alternative to alleviate chemotherapy-induced thrombocytopenia (CIT), allowing patients with cancer to resume chemotherapy regimens.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Irreversible Electroporation of the Femoral Neurovascular Bundle: Imaging and Histologic Evaluation in a Swine Model

Simon Sin Man Wong, FRCR, Joyce Wai Yi Hui, FRCR, Anthony Wing Hung Chan, FRCPA, Cheuk Man Chu, FRCR, Dewi Kenneth Rowlands, PhD, Simon Chun Ho Yu, MD

Purpose: To evaluate imaging, histologic changes, and safety of irreversible electroporation (IRE) on the femoral neurovascular bundle in a swine model.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Comparison of Acute Histologic and Biomechanical Effects of Radiofrequency Ablation and Cryoablation on Periarticular Structures in a Swine Model

Eric M. Vikingstad, MD, PhD, Gustaaf G. de Ridder, MD, PhD, Richard R. Glisson, BS, Diana M. Cardona, MD, Devon DiPalma, William C. Eward, MD, DVM, Brian E. Brigman, MD, PhD, Rendon C. Nelson, MD, Charles Y. Kim, MD

Purpose: To compare the acute effects of radiofrequency (RF) ablation and cryoablation on the structural integrity of nontarget periarticular tissues that may be placed at risk during percutaneous bone ablation.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Magnetic Resonance–Monitored Coaxial Electrochemical Ablation—Preliminary Evaluation of Technical Feasibility

Benjamin H. Ge, MD, Charles N. Weber, MD, Joseph C. Wildenberg, MD, PhD, Gregory J. Nadolski, MD, Terence P. Gade, MD, PhD, Stephen J. Hunt, MD, PhD, Michael C. Soulen, MD, Maxim Itkin, MD

Purpose: To evaluate the technical feasibility of a coaxial electrode configuration to rapidly create a mechanically defined electrochemical ablation zone monitored by magnetic resonance (MR) imaging in real time.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma

Yeonjung Ha, MD, Seungbong Han, PhD, Ju Hyun Shim, MD, Gi-Young Ko, MD, Hyun-Ki Yoon, MD, Kyu-Bo Sung, MD, Danbi Lee, MD, Kang Mo Kim, MD, Young-Suk Lim, MD, Young-Hwa Chung, MD, Yung Sang Lee, MD, Han Chu Lee, MD

Purpose: To construct prognostic nomograms capable of estimating individual probabilities of tumor progression and overall survival (OS) at specific time points during serial transarterial chemoembolization for hepatocellular carcinoma (HCC).

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases

Steven J. Lahti, BS, Minzhi Xing, MD, Di Zhang, BS, James J. Lee, MD, PhD, Michael J. Magnetta, MD, Hyun S. Kim, MD

Purpose: To evaluate Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status as a prognostic factor for survival after yttrium-90 (90Y) radioembolization for colorectal cancer (CRC) liver metastases.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread

Julie N. Leal, MD, Mithat Gonen, PhD, Anne M. Covey, MD, Joseph P. Erinjeri, MD, PhD, George Getrajdman, MD, Constantinos T. Sofocleous, MD, Michael D’Angelica, MD, Ronald P. DeMatteo, MD, Ghassan K. Abou-Alfa, MD, William R. Jarnagin, MD, Yuman Fong, MD, Karen T. Brown, MD

Purpose: To evaluate the use of locoregional therapy in patients with hepatocellular carcinoma (HCC) with and without extrahepatic disease (EHD).

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization

Nishita Kothary, MD, Chris Takehana, MD, Kerstin Mueller, PhD, Patrick Sullivan, Ali Tahvildari, MD, Vishal Sidhar, MD, Jarrett Rosenberg, PhD, John D. Louie, MD, Daniel Y. Sze, MD, PhD

Purpose: Hepatocellular carcinomas (HCCs) bridging two or more Couinaud–Bismuth segments of the liver (“watershed tumors”) can recruit multiple segmental arteries. The primary hypothesis of this study was that fewer watershed tumors show complete response (CR) after chemoembolization, with shorter time to local recurrence. Secondary analysis on the impact on transplantation eligibility in the presence of progressive disease was also performed.

01 agosto 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein

Sae Rom Chung, MD, Jin Hyoung Kim, MD, Hyun-Ki Yoon, MD, Gi-Young Ko, MD, Dong Il Gwon, MD, Ji Hoon Shin, MD, Ho-Young Song, MD, Heung Kyu Ko, MD, Sang Min Yoon, MD

Purpose: To evaluate the safety and survival outcome of chemoembolization plus radiation therapy (RT) in patients with hepatocellular carcinoma (HCC) with main portal vein (PV) tumor thrombosis.